Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Ellen Lubman on Board of Advisors at TMRW Life Scienc
As Chief Business Officer of Impel Neuropharma, Ms. Lubman leads corporate development activities and strategy for the private neuroscience therapeutics company.
Prior to joining Impel, she served as the Vice President of External Science & Innovation at Allergan, where she was responsible for strategic expansion of the company’s pipeline in a variety of disease areas, including women’s health.
“We are thrilled to have Ellen join our Advisory Board,” said Alan Murray, TMRW’s Founder and Co-CEO. “Her deep interest in and understanding of the assisted reproductive technology landscape and her experience as a senior leader at life sciences companies at every stage of development make her an ideal advisor for TMRW, especially regarding strategic partnering and financing initiatives.”
Ms. Lubman has 20 years of biopharmaceutical corporate development and Wall Street industry experience, including roles at Kadmon Pharmaceuticals, Bristol-Myers Squibb, Celtic Pharma Management, L.P. and Robertson Stephens. She is a member of the Board of Directors of Dauntless Pharmaceuticals and GeneCentric Therapeutics.
In coming decades, a rapidly scaling fertility industry and increased access to IVF therapies will be responsible for nearly 300 million global births — almost all of which will rely upon frozen fertility cells. To meet this rapidly growing demand, TMRW has created the first fully Robotic Process Automation (RPA) platform designed specifically for IVF. Already experiencing rapid market adoption, TMRW is poised to become the global standard for cryo-preservation and fertility cell management. IVF clinicians have embraced TMRW’s RPA platform because it replaces an outdated analog IVF cryo-management function with proven risk-mitigating Robotic Process Automation technology.
TMRW provides the world’s first complete RFID cryo-temperature compatible digital chain of custody for all fertility cells—including embryos and gametes. TMRW software is constantly vigilant and automates 17,000 daily environmental “health checks” that ensure the safety and security of the world’s most precious cells.
TMRW’s co-founders, Joshua Abram, Alan Murray and Dr. Jeff Port, are serial tech and life sciences entrepreneurs. Their immediate prior ventures sold for a combined sum of more than $1 billion.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.